Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Dysmenorrhea
- Fatigue
- Headache, Migraine
- Mood Disturbance
- Nausea
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 21 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04091789
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Debra Kimless, M.D. Pure Green
Get Well Soon